Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
about
Urinary Markers of Tubular Injury in HIV-Infected PatientsAssociation of low level viremia with inflammation and mortality in HIV-infected adultsChanges in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsSerum albumin and kidney function decline in HIV-infected womenA chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM)The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) studyCystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C.Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infectionReductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Renal disease in HIV-infected individualsAPOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Markers of renal disease and function are associated with systemic inflammation in HIV infection.Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) studyCystatin C-Based Evaluation of Kidney Function of HIV-Infected Children in Benin City, Southern Nigeria.Urinary markers of kidney injury and kidney function decline in HIV-infected womenThe Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART RegimensRisk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.Accelerated Aging in HIV Patients.Association of tenofovir exposure with kidney disease risk in HIV infection.Update on cystatin C: incorporation into clinical practice.The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected womenDecreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infectionDoes HIV infection promote early kidney injury in women?Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).Impaired Urine Dilution Capability in HIV Stable Patients.Renal issues in HIV infection.
P2860
Q26738912-7604D75B-B0BF-4E52-8405-06B1AE31B2BAQ28743237-B19DF32D-2942-4044-9CC5-2CD681A4E778Q30842348-3D15301D-B926-47D6-9C57-6B84DAED584EQ33625213-CDB5DF6D-63C5-4F82-9FDE-BE692621A01DQ33926735-FC8B8F29-2F3A-47A9-879A-8FFD054CF838Q34048920-46A6C9AF-A602-4695-A68C-30FF837DCB79Q34254770-E19531F4-AAEC-4209-BA67-395EF1EA83DBQ34301401-2E8C9E6D-F267-4E8F-A5D4-36CC75618A21Q34584634-11B02DE3-D595-4470-B8D1-35F68DE4A162Q34736194-74CFCEDD-18FD-4211-B610-15753FF51920Q34736818-15E9028A-08FE-4BC7-82FE-EC0C6465C447Q35000346-B61B3C4E-7F0E-44C7-A2E6-55DB44859F09Q35060772-3D1DA98C-1D63-4E84-B385-0740755EACB7Q35071954-9F97CD54-3179-4BB1-82B3-8BC6713F5E67Q35077530-540B81FD-F5CC-4BBB-AA46-CD92C49BFE48Q35230397-80815BFE-E190-4E2A-813B-AC6FDAA98FB6Q35652795-8712E5D8-2DB9-4C25-BF2D-0A8A457D2473Q35698442-CD8F5D55-B6D1-4D6C-8FE9-A2F58532F3F5Q35715828-407D3074-DF5B-4653-9D0D-FA88E97EAE13Q35756256-126D500E-6550-4BB7-A0C7-77C469B26048Q35883947-895DF7D9-8B3B-450D-ADB3-776917BDF498Q35994939-389F697B-62B2-4C4A-BAA4-F178FDC52F44Q36206108-4CC088B7-8522-4F26-84EF-1169506FDD99Q36388998-42784D88-0318-469A-92FC-75CBBDE79DBCQ36425231-9BEB8DD4-C21E-4234-9EA9-6BD340DADF9AQ36431302-33DE1BF6-8F92-4C65-9FD2-45AA71BFD277Q36472367-EC8DEDD1-987A-4928-BEAD-99205A300571Q36492436-588931A7-1805-4EFC-82FE-65A4D8C1D1AFQ36852879-92BED065-FF93-491A-9A5E-0AA20AAD6E2DQ36919221-1CF43931-EC1C-45B5-B1B2-35ED7DC8F3E7Q37077982-284AC6D2-7ACD-4CA4-AE65-8DEFB3976FCDQ37126287-FF7C121F-45DB-4EA2-9BAA-BBA90E7355BDQ37354871-E716CC37-2918-484B-A49B-489AAFADF6CCQ37574064-0062EB01-0BC8-43B5-AC95-7ED830365BDEQ37600614-18FA1999-1D4D-4374-B72C-144601F0AE2DQ37600838-6C208CD4-36C7-4D8E-A88B-CD0FCF1B669CQ37626254-0AE9C4C6-C38D-4DF4-9A18-6E510067F022Q37684606-5FBD3F48-5ABB-4D55-BF6D-35A376499145Q37706095-A305B11C-C6DD-4BE5-A8C7-94B19D74F11AQ37885232-04128957-0BB0-4A7D-AC41-7410C89317DA
P2860
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@ast
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@en
type
label
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@ast
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@en
prefLabel
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@ast
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@en
P2093
P2860
P1476
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
@en
P2093
Carl Grunfeld
Cynthia L Gibert
Lynda A Szczech
Michael S Saag
Peter Bacchetti
Phyllis C Tien
Rebecca Scherzer
P2860
P304
P356
10.1053/J.AJKD.2010.05.019
P577
2010-08-14T00:00:00Z